purchase customization

1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnostic Radiopharmaceuticals
1.2.3 Therapy Radiopharmaceuticals
1.2.4 Enriched Stable Isotopes
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Industrial
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Estimates and Forecasts 2017-2028
2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Estimates and Forecasts 2017-2028
2.3 Global Radiopharmaceuticals in Nuclear Medical Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Radiopharmaceuticals in Nuclear Medical Sales by Region
2.4.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2022)
2.4.2 Global Sales Radiopharmaceuticals in Nuclear Medical by Region (2023-2028)
2.5 Global Radiopharmaceuticals in Nuclear Medical Revenue by Region
2.5.1 Global Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2022)
2.5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers
3.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Sales (2017-2022)
3.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medical in 2021
3.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers
3.2.1 Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2017-2022)
3.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medical Revenue in 2021
3.3 Global Radiopharmaceuticals in Nuclear Medical Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Radiopharmaceuticals in Nuclear Medical Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Type
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Historical Sales by Type (2017-2022)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Forecasted Sales by Type (2023-2028)
4.1.3 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Type (2017-2028)
4.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type
4.2.1 Global Radiopharmaceuticals in Nuclear Medical Historical Revenue by Type (2017-2022)
4.2.2 Global Radiopharmaceuticals in Nuclear Medical Forecasted Revenue by Type (2023-2028)
4.2.3 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Type (2017-2028)
4.3 Global Radiopharmaceuticals in Nuclear Medical Price by Type
4.3.1 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2017-2022)
4.3.2 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Application
5.1.1 Global Radiopharmaceuticals in Nuclear Medical Historical Sales by Application (2017-2022)
5.1.2 Global Radiopharmaceuticals in Nuclear Medical Forecasted Sales by Application (2023-2028)
5.1.3 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Application (2017-2028)
5.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Application
5.2.1 Global Radiopharmaceuticals in Nuclear Medical Historical Revenue by Application (2017-2022)
5.2.2 Global Radiopharmaceuticals in Nuclear Medical Forecasted Revenue by Application (2023-2028)
5.2.3 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Application (2017-2028)
5.3 Global Radiopharmaceuticals in Nuclear Medical Price by Application
5.3.1 Global Radiopharmaceuticals in Nuclear Medical Price by Application (2017-2022)
5.3.2 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Application (2023-2028)
6 North America
6.1 North America Radiopharmaceuticals in Nuclear Medical Market Size by Type
6.1.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
6.1.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2028)
6.2 North America Radiopharmaceuticals in Nuclear Medical Market Size by Application
6.2.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
6.2.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2028)
6.3 North America Radiopharmaceuticals in Nuclear Medical Market Size by Country
6.3.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2028)
6.3.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medical Market Size by Type
7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2028)
7.2 Europe Radiopharmaceuticals in Nuclear Medical Market Size by Application
7.2.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
7.2.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2028)
7.3 Europe Radiopharmaceuticals in Nuclear Medical Market Size by Country
7.3.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2028)
7.3.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size by Type
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2028)
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size by Application
8.2.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
8.2.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2028)
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Size by Region
8.3.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Region (2017-2028)
8.3.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Radiopharmaceuticals in Nuclear Medical Market Size by Type
9.1.1 Latin America Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
9.1.2 Latin America Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2028)
9.2 Latin America Radiopharmaceuticals in Nuclear Medical Market Size by Application
9.2.1 Latin America Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
9.2.2 Latin America Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2028)
9.3 Latin America Radiopharmaceuticals in Nuclear Medical Market Size by Country
9.3.1 Latin America Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2028)
9.3.2 Latin America Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Size by Type
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Type (2017-2028)
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Type (2017-2028)
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Size by Application
10.2.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Application (2017-2028)
10.2.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Application (2017-2028)
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Size by Country
10.3.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Country (2017-2028)
10.3.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Imaging Recent Developments
11.2 Cambridge Isotope Laboratories
11.2.1 Cambridge Isotope Laboratories Corporation Information
11.2.2 Cambridge Isotope Laboratories Overview
11.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cambridge Isotope Laboratories Recent Developments
11.3 Cardinal Health
11.3.1 Cardinal Health Corporation Information
11.3.2 Cardinal Health Overview
11.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cardinal Health Recent Developments
11.4 Medtronic
11.4.1 Medtronic Corporation Information
11.4.2 Medtronic Overview
11.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Medtronic Recent Developments
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Corporation Information
11.5.2 Eczacibasi-Monrol Overview
11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eczacibasi-Monrol Recent Developments
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Corporation Information
11.6.2 Fujifilm Holdings Corporation Overview
11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fujifilm Holdings Corporation Recent Developments
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
11.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Developments
11.8 IBA Group
11.8.1 IBA Group Corporation Information
11.8.2 IBA Group Overview
11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 IBA Group Recent Developments
11.9 Lantheus Medical Imaging
11.9.1 Lantheus Medical Imaging Corporation Information
11.9.2 Lantheus Medical Imaging Overview
11.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lantheus Medical Imaging Recent Developments
11.10 Nordion
11.10.1 Nordion Corporation Information
11.10.2 Nordion Overview
11.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nordion Recent Developments
11.11 Ntp Radioisotopes
11.11.1 Ntp Radioisotopes Corporation Information
11.11.2 Ntp Radioisotopes Overview
11.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ntp Radioisotopes Recent Developments
11.12 Siemens Healthcare
11.12.1 Siemens Healthcare Corporation Information
11.12.2 Siemens Healthcare Overview
11.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Siemens Healthcare Recent Developments
11.13 Taiyo Nippon Sanso Corporation
11.13.1 Taiyo Nippon Sanso Corporation Corporation Information
11.13.2 Taiyo Nippon Sanso Corporation Overview
11.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Taiyo Nippon Sanso Corporation Recent Developments
11.14 Urenco Limited
11.14.1 Urenco Limited Corporation Information
11.14.2 Urenco Limited Overview
11.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Urenco Limited Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Urenco Limited Recent Developments
11.15 Rotem Industries
11.15.1 Rotem Industries Corporation Information
11.15.2 Rotem Industries Overview
11.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Rotem Industries Radiopharmaceuticals in Nuclear Medical Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Rotem Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Radiopharmaceuticals in Nuclear Medical Industry Chain Analysis
12.2 Radiopharmaceuticals in Nuclear Medical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceuticals in Nuclear Medical Production Mode & Process
12.4 Radiopharmaceuticals in Nuclear Medical Sales and Marketing
12.4.1 Radiopharmaceuticals in Nuclear Medical Sales Channels
12.4.2 Radiopharmaceuticals in Nuclear Medical Distributors
12.5 Radiopharmaceuticals in Nuclear Medical Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Radiopharmaceuticals in Nuclear Medical Industry Trends
13.2 Radiopharmaceuticals in Nuclear Medical Market Drivers
13.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
13.4 Radiopharmaceuticals in Nuclear Medical Market Restraints
14 Key Findings in The Global Radiopharmaceuticals in Nuclear Medical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer